Toronto-based Supreme Pharmaceuticals (TSXV: FIRE) announced that its subsidiary 7ACRES recorded $1.5 million in its first month of retail sales. The results will be recorded in Supreme’s quarterly results ending September 30th.
7ACRES operates a 342,000 sq ft Hybrid Greenhouse facility that combines the best of both indoor greenhouse growing, and natural sun growing, to create a premium cannabis product that will sell for a higher price and margin. This gives it both optimum full-sun growing conditions associated with natural conditions, with the year-round production of a greenhouse. This will give it a premium brand quality and cost. 7ACRES will not attempt to be a low-cost producer.
Source: Supreme Pharmaceuticals